Stay updated on Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.4%
- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check44 days agoChange DetectedThe webpage has updated the study details for the Phase 1/1b trial of sitravatinib in combination with nivolumab and ipilimumab for Clear-Cell Renal Cell Carcinoma, including a revision in the study version and a change in the description of the study's cohorts and treatment model.SummaryDifference20%
- Check51 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check94 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check109 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.